Your Cart is Empty

  • Add description, images, menus and links to your mega menu

  • A column with no settings can be used as a spacer

  • Link to your collections, sales and even external links

  • Add up to five columns

  • December 08, 2023 2 min read



    Chaga, a fungus renowned for its purported health benefits, has garnered attention for its potential role in anxiety management. This article aims to explore the available evidence, drawing insights from UK government agencies, the NHS, and reputable academic works from distinguished UK universities and medical professionals.

    Understanding Chaga's Composition

    Before delving into its potential impact on anxiety, a foundational understanding of Chaga (Inonotus obliquus) is crucial. Rich in bioactive compounds like polysaccharides and polyphenols, Chaga's purported adaptogenic properties prompt speculation about its anxiety-alleviating potential.

    Chaga and Anxiety: The Anecdotes

    Stress-Relief Claims

    Enthusiasts suggest that Chaga's adaptogenic nature contributes to stress reduction, potentially alleviating anxiety symptoms. However, these claims are largely anecdotal and require scrutiny against scientific evidence.

    Individual Responses

    It's essential to consider individual variability in responses to Chaga. While some individuals may report a sense of calmness, the subjective nature of these experiences warrants a closer examination.

    Expert Opinions and Academic Research

    Limited Clinical Evidence

    A comprehensive review of academic works from renowned UK universities reveals a scarcity of direct clinical trials examining Chaga's efficacy in anxiety management. Rigorous studies are imperative to substantiate claims and establish a scientific foundation.

    Potential Mechanisms

    Some academic discussions propose that Chaga's anti-inflammatory and antioxidant properties may indirectly contribute to anxiety relief. However, the precise mechanisms and dosage considerations necessitate further exploration.

    NHS Perspective

    The National Health Service (NHS) acknowledges Chaga's traditional use and generally safe profile but remains cautious in endorsing specific claims related to anxiety. Individuals experiencing anxiety are advised to consult healthcare professionals for evidence-based interventions.

    Expert Recommendations

    Healthcare Professional Guidance

    Leading medical professionals in the UK stress the importance of consulting healthcare providers before incorporating Chaga into anxiety management. Individualized care and comprehensive mental health support remain crucial.

    Adjunct Therapy Consideration

    While some experts posit Chaga as a potential adjunct therapy for anxiety, its integration into treatment plans should be guided by evidence-based practices and healthcare professional advice.

    Regulatory Oversight

    The Medicines and Healthcare products Regulatory Agency (MHRA), the UK government agency overseeing medicines and healthcare products, does not currently regulate Chaga for anxiety. This underscores the importance of evidence-based practices in anxiety care.


     while anecdotal reports suggest that Chaga may contribute to stress reduction and anxiety relief, the scientific evidence supporting these claims is limited. The cautious stance of UK health authorities and the NHS highlights the need for more robust studies to draw definitive conclusions about Chaga's impact on anxiety. Individuals interested in exploring Chaga for anxiety management should approach it with prudence, recognizing the current gaps in scientific understanding and consulting healthcare professionals for personalized advice.